AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17986056 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose UVA1 phototherapy (40 J/cm²), 3 times weekly for 14 weeks
Number of subjects: 9
Study 17986056 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated hand)
Number of subjects: 9
Study 16179665 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil split doses
Number of subjects: 56
Study 16179665 — intervention group
Group type: COMPARATOR
Intervention: Modafinil once-daily (200 mg)
Number of subjects: 56
Study 12487756 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication plus 1 g/day Spirulina (group II)
Number of subjects: 23
Study 12487756 — intervention group
Group type: COMPARATOR
Intervention: Medication (group I)
Number of subjects: 23
Study 9808548 — intervention group
Group type: EXPERIMENTAL
Intervention: DHAP (2 courses)
Number of subjects: 215
Study 9808548 — intervention group
Group type: COMPARATOR
Intervention: BEAC followed by ABMT
Number of subjects: 215
Study 9808548 — intervention group
Group type: COMPARATOR
Intervention: DHAP (4 additional courses)
Number of subjects: 215
Study 9808548 — intervention group
Group type: COMPARATOR
Intervention: BEAC
Number of subjects: 215
Study 7621847 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem formulation 1
Number of subjects: 20
Study 7621847 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem formulation 2
Number of subjects: 20
Study 2196108 — intervention group
Group type: EXPERIMENTAL
Intervention: Corynebacterium parvum (CP) plus chemotherapy (l-phenylalanine mustard (L-PAM) and 5-fluorouracil (PF))
Number of subjects: 0
Study 2196108 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (l-phenylalanine mustard (L-PAM) and 5-fluorouracil (PF))
Number of subjects: 0
Study 100818 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylphenidate (0.5 mg/kg)
Number of subjects: 0
Study 100818 — intervention group
Group type: COMPARATOR
Intervention: Oral methylphenidate (1.0 mg/kg)
Number of subjects: 0
Study 30799062 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-observed therapy (VOT)
Number of subjects: 226
Study 30799062 — intervention group
Group type: COMPARATOR
Intervention: Directly observed treatment (DOT)
Number of subjects: 226
Study 28962734 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined orthodontic-periodontic treatment
Number of subjects: 117
Study 28962734 — intervention group
Group type: COMPARATOR
Intervention: Basic periodontic treatment
Number of subjects: 117
Study 28962734 — intervention group
Group type: COMPARATOR
Intervention: Normal group (healthy individuals)
Number of subjects: 117
Study 25978327 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid (three laminated cards with graphics and pros/cons)
Number of subjects: 130
Study 25978327 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 130
Study 23430315 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (2000 IU daily for 6 weeks)
Number of subjects: 36
Study 23430315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 22174166 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20 mg/day)
Number of subjects: 120
Study 22174166 — intervention group
Group type: COMPARATOR
Intervention: Low fat diet (first control group)
Number of subjects: 120
Study 22174166 — intervention group
Group type: COMPARATOR
Intervention: No treatment (second control group)
Number of subjects: 120
Study 19801932 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of L-alanine-L-glutamine dipeptide (0.40 g/kg/d; equal to 0.25 g of free glutamine) in Ala-Glu group (n = 212)
Number of subjects: 428
Study 19801932 — intervention group
Group type: COMPARATOR
Intervention: No supplementation in control group (n = 216)
Number of subjects: 428
Study 16951263 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (ET) in Group A, enrolled in a 3-month exercise-based cardiac rehabilitation (CR) programme.
Number of subjects: 40
Study 16951263 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B) with generic instructions to continue physical activity.
Number of subjects: 40
Study 14716846 — intervention group
Group type: EXPERIMENTAL
Intervention: HB vaccination (0, 1, 6 month regimen)
Number of subjects: 44
Study 14716846 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HBV markers)
Number of subjects: 44
Study 11606013 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous-intensity exercise program (16 weeks, 3 days/week, 30 min/day at approximately 80% of heart rate reserve)
Number of subjects: 11
Study 11606013 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-exercising)
Number of subjects: 11
Study 10481381 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate variability test in patients with advanced PD
Number of subjects: 22
Study 10481381 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate variability test in patients with early PD
Number of subjects: 22
Study 10481381 — intervention group
Group type: COMPARATOR
Intervention: Age-matched controls
Number of subjects: 22
Study 7956268 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in the SOLVD trial
Number of subjects: 3522
Study 3307282 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliding screw plate
Number of subjects: 104
Study 3307282 — intervention group
Group type: COMPARATOR
Intervention: 4 ASIF cancellous bone screws
Number of subjects: 104
Study 29976501 — intervention group
Group type: EXPERIMENTAL
Intervention: Consolidation chemotherapy (2 cycles of capecitabine and oxaliplatin: capecitabine 1700 mg/m2 per day from day 1 to 14, oxaliplatin 100 mg/m2 on day 1, every 3 weeks) after CRT.
Number of subjects: 110
Study 29976501 — intervention group
Group type: COMPARATOR
Intervention: Preoperative chemoradiation therapy (CRT) with capecitabine (50.4 Gy in 28 fractions) followed by TME.
Number of subjects: 110
Study 27871086 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam cream (active agent)
Number of subjects: 0
Study 27871086 — intervention group
Group type: COMPARATOR
Intervention: Placebo foam cream
Number of subjects: 0
Study 24762588 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole, amoxicillin, and clarithromycin for 1 week (T group)
Number of subjects: 552
Study 24762588 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P group)
Number of subjects: 552
Study 22452326 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted preload optimisation using a supine stroke volume variation value < 14%
Number of subjects: 45
Study 22452326 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with low supine stroke volume variation
Number of subjects: 45
Study 22452326 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with high supine stroke volume variation who received volume preload
Number of subjects: 45
Study 20485956 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mL of hyperbaric bupivacaine (10 mg) and sufentanil (5 microg)
Number of subjects: 40
Study 20485956 — intervention group
Group type: COMPARATOR
Intervention: 3 mL of hyperbaric bupivacaine (10 mg) and sufentanil (5 microg)
Number of subjects: 40
Study 18321585 — intervention group
Group type: EXPERIMENTAL
Intervention: CeeOn (highly refractive index silicone IOL with a sharp optic edge)
Number of subjects: 288
Study 18321585 — intervention group
Group type: COMPARATOR
Intervention: AcrySof (acrylic IOL with a sharp optic edge)
Number of subjects: 288
Study 18321585 — intervention group
Group type: COMPARATOR
Intervention: PhacoFlex (highly refractive index silicone IOL with a round optic edge)
Number of subjects: 288
Study 16042023 — intervention group
Group type: EXPERIMENTAL
Intervention: P300 evoked potential analyses of cortical response to acoustic stimulation in the oddball paradigm (AS-Group)
Number of subjects: 39
Study 16042023 — intervention group
Group type: COMPARATOR
Intervention: Control group (C-Group)
Number of subjects: 39
Study 11952807 — intervention group
Group type: EXPERIMENTAL
Intervention: BQ‐123 (60 microg min(‐1)), a specific ETA‐receptor antagonist
Number of subjects: 10
Study 11952807 — intervention group
Group type: COMPARATOR
Intervention: Ang II (0.65, 1.25, 2.5, 5 ng kg(‐1) min(‐1) for 15 min per dose level)
Number of subjects: 10
Study 10732594 — intervention group
Group type: EXPERIMENTAL
Intervention: Kogan's (1961) Attitude Toward Old People's Scale administered before clinical experiences
Number of subjects: 100
Study 10732594 — intervention group
Group type: EXPERIMENTAL
Intervention: Kogan's (1961) Attitude Toward Old People's Scale administered after clinical experiences
Number of subjects: 100
Study 7677537 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid regimen: 1 g of methylprednisolone sodium succinate intravenously before bypass and 4 mg of dexamethasone every 6 hours for four doses during the first 24 hours of recovery.
Number of subjects: 19
Study 7677537 — intervention group
Group type: COMPARATOR
Intervention: Nonsteroid group (control).
Number of subjects: 19
Study 2209305 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (0.1 and 0.2 mg/day)
Number of subjects: 37
Study 2209305 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (400 mg 3 times/day)
Number of subjects: 37
Study 2209305 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for both clonidine and pentoxifylline)
Number of subjects: 37
Study 775954 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous digoxin (0.01 mg/kg over 10 minutes)
Number of subjects: 33
Study 775954 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 33
Study 775954 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous digoxin
Number of subjects: 33
Study 31282193 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training (experimental group, n=23)
Number of subjects: 45
Study 31282193 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=22)
Number of subjects: 45
Study 28662677 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT) with pembrolizumab (200 mg intravenously, every 3 weeks)
Number of subjects: 13
Study 28662677 — intervention group
Group type: COMPARATOR
Intervention: Stereotactic body radiotherapy (SBRT)
Number of subjects: 13
Study 26295268 — intervention group
Group type: EXPERIMENTAL
Intervention: IVR reminder only
Number of subjects: 12285
Study 26295268 — intervention group
Group type: COMPARATOR
Intervention: Postcard reminder only
Number of subjects: 12285
Study 26295268 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcard plus IVR reminder
Number of subjects: 12285
Study 23808756 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription headache medication
Number of subjects: 551
Study 21854276 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise as an augmentation treatment
Number of subjects: 0
Study 19833592 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous Hemobag blood transfusion (AHBT)
Number of subjects: 60
Study 19833592 — intervention group
Group type: COMPARATOR
Intervention: Allogenic blood transfusion (ABT)
Number of subjects: 60
Study 17108629 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia Health Educational Program (MHEP) presented by a Registered Nurse (RN)
Number of subjects: 60
Study 17108629 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflet designed using the exact contents of the MHEP
Number of subjects: 60
Study 17108629 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal information from the RN
Number of subjects: 60
Study 17108629 — intervention group
Group type: COMPARATOR
Intervention: Conventional preoperative information by the attending surgeon and anesthesiologist (Control Group D)
Number of subjects: 60
Study 15651513 — intervention group
Group type: EXPERIMENTAL
Intervention: Air
Number of subjects: 80
Study 15651513 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O + O2
Number of subjects: 80
Study 15651513 — intervention group
Group type: EXPERIMENTAL
Intervention: Saline
Number of subjects: 80
Study 15651513 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% lidocaine
Number of subjects: 80
Study 11704169 — intervention group
Group type: EXPERIMENTAL
Intervention: Transperitoneal laparoscopic Burch procedure using nonabsorbable sutures (group A)
Number of subjects: 60
Study 11704169 — intervention group
Group type: COMPARATOR
Intervention: Transperitoneal laparoscopic Burch procedure using Prolene mesh (group B)
Number of subjects: 60
Study 9052291 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 330
Study 9052291 — intervention group
Group type: COMPARATOR
Intervention: Control (no nitrous oxide)
Number of subjects: 330
Study 8183752 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous fluid therapy (2 litres of dextrose-saline/24 hours)
Number of subjects: 34
Study 8183752 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fluid therapy (2 litres of dextrose-saline/24 hours)
Number of subjects: 34
Study 8183752 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous fluid therapy
Number of subjects: 34
Study 8183752 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fluid therapy
Number of subjects: 34
Study 3070826 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethamsylate (2 g/day in four equal doses)
Number of subjects: 9
Study 3070826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31865579 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant-derived compounds with larvicidal activity; specific compounds not detailed
Number of subjects: 263
Study 29257140 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMI; 50 mg)
Number of subjects: 292
Study 29257140 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (ESC; 10 mg)
Number of subjects: 292
Study 29257140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study 28160761 — intervention group
Group type: EXPERIMENTAL
Intervention: Nartana herbal formulation (450 mg, 2 ×/d for first 15 d, then 1 ×/d)
Number of subjects: 80
Study 28160761 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac (50 mg, 2 ×/d for first 15 d, then 100 mg, 1 ×/d)
Number of subjects: 80
Study 25724974 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based intervention
Number of subjects: 0
Study 25724974 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 24066262 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention group
Number of subjects: 268
Study 24066262 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 268
Study 21848870 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 31
Study 21848870 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 18979387 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) over ventral premotor cortex (vPMc)
Number of subjects: 0
Study 18979387 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 0
Study 18979387 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-related rTMS over extrastriate body area (EBA)
Number of subjects: 0
Study 16918762 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronabinol (DRO) 5 mg b.i.d.
Number of subjects: 30
Study 16918762 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 30
Study 15598119 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring sounds (6 sounds with 5 levels each)
Number of subjects: 6
Study 11197587 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanamivir 10 mg inhaled twice daily
Number of subjects: 0
Study 11197587 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir 75 mg orally twice daily
Number of subjects: 0
Study 11197587 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanamivir 10 mg inhaled once daily for prophylaxis
Number of subjects: 0
Study 11197587 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir 75 mg orally once daily for prophylaxis
Number of subjects: 0
Study 11197587 — intervention group
Group type: COMPARATOR
Intervention: Oseltamivir
Number of subjects: 0
Study 11197587 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanamivir in patients with asthma or COPD
Number of subjects: 0
Study 9103722 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily urge intensity measures
Number of subjects: 214
Study 9103722 — intervention group
Group type: EXPERIMENTAL
Intervention: Average duration of temptation episodes
Number of subjects: 214
Study 9103722 — intervention group
Group type: EXPERIMENTAL
Intervention: Urge intensity at waking
Number of subjects: 214
Study 9103722 — intervention group
Group type: EXPERIMENTAL
Intervention: Urge intensity in temptations
Number of subjects: 214
Study 9103722 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of temptation
Number of subjects: 214
Study 7957037 — intervention group
Group type: EXPERIMENTAL
Intervention: Left-sided cervical electrical stimulation at 30 Hz (high stimulation)
Number of subjects: 14
Study 7957037 — intervention group
Group type: EXPERIMENTAL
Intervention: Left-sided cervical electrical stimulation at 1 Hz (low stimulation)
Number of subjects: 14
Study 7957037 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled ipratropium bromide (160 micrograms, dry powder) added to stimulation in one patient with obstructive lung disease
Number of subjects: 14
Study 7957037 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable frequency and current stimulation (10-87 Hz and 0.5-2.5 mA)
Number of subjects: 14
Study 7957037 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense vagal stimulation in patients with obstructive lung disease
Number of subjects: 14
Study 3066896 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline or Imipramine treatment
Number of subjects: 82
Study 30741862 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill training (TM)
Number of subjects: 64
Study 30741862 — intervention group
Group type: EXPERIMENTAL
Intervention: Overground training (TR)
Number of subjects: 64
Study 30741862 — intervention group
Group type: COMPARATOR
Intervention: Control group (CONTROL)
Number of subjects: 64
Study 31549943 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic CT myocardial perfusion imaging (MPI)
Number of subjects: 86
Study 31549943 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning (ML)‐based CT fractional flow reserve (FFR)
Number of subjects: 86
Study 28661170 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet computer
Number of subjects: 212
Study 28661170 — intervention group
Group type: COMPARATOR
Intervention: Paper-and-pencil materials
Number of subjects: 212
Study 26347440 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist Brief Intervention (BI)
Number of subjects: 836
Study 26347440 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer Brief Intervention (BI)
Number of subjects: 836
Study 26347440 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-ED session
Number of subjects: 836
Study 26347440 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 836
Study 23681144 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated alert recommending lung-protective ventilation with a Vt of 6 cc/kg predicted body weight
Number of subjects: 0
Study 23681144 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 0
Study 20663568 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep transcranial magnetic stimulation (DTMS) with positive cognitive-emotional reactivation
Number of subjects: 57
Study 20663568 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep transcranial magnetic stimulation (DTMS) with negative cognitive-emotional reactivation
Number of subjects: 57
Study 19006791 — intervention group
Group type: EXPERIMENTAL
Intervention: Testicular sperm extraction (TESE)
Number of subjects: 62
Study 17573205 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced cognitive-behavioral therapy (MET+CBT)
Number of subjects: 74
Study 17573205 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 74
Study 15019013 — intervention group
Group type: EXPERIMENTAL
Intervention: PAPNET
Number of subjects: 21747
Study 15019013 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cytology and histology analysis
Number of subjects: 21747
Study 11579624 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (100 mg/day)
Number of subjects: 183
Study 11579624 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study 11579624 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 183
Study 9495400 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron (0.1 mg/kg, n = 26)
Number of subjects: 74
Study 9495400 — intervention group
Group type: EXPERIMENTAL
Intervention: dimenhydrinate (0.5 mg/kg, n = 25)
Number of subjects: 74
Study 9495400 — intervention group
Group type: COMPARATOR
Intervention: placebo (saline, n = 23)
Number of subjects: 74
Study 7852614 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% methylene blue gel irrigated at 0, 1, and 4 weeks
Number of subjects: 0
Study 7852614 — intervention group
Group type: COMPARATOR
Intervention: Sterile water irrigation
Number of subjects: 0
Study 7852614 — intervention group
Group type: COMPARATOR
Intervention: Subgingival debridement
Number of subjects: 0
Study 7852614 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue incorporated into a slow-release device
Number of subjects: 0
Study 3137835 — intervention group
Group type: EXPERIMENTAL
Intervention: RO 15‐1788
Number of subjects: 57
Study 3137835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 30964778 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (1,500 IU/day) for 28 days
Number of subjects: 262
Study 29309040 — intervention group
Group type: EXPERIMENTAL
Intervention: Mulligan Mobilization with Movement (MWM)
Number of subjects: 40
Study 29309040 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic Mobilization (OM)
Number of subjects: 40
Study 29309040 — intervention group
Group type: COMPARATOR
Intervention: Both MWM and OM
Number of subjects: 40
Study 27659078 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetric‐N‐Flow (nano‐hybrid composite)
Number of subjects: 100
Study 27659078 — intervention group
Group type: COMPARATOR
Intervention: Transbond Supreme LV (low viscosity composite)
Number of subjects: 100